🎉 Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application

- This event has passed.
Event Series:
Regulations
Practitioners Roles in Psychedelic-Assisted Therapy
March 9 @ 6:00 pm - 7:00 pm

There are many important roles that work together in psychedelic-assisted therapy.
Psychedelic-assisted therapy has largely received the attention of therapy providers like psychologists and clinical counselors. As a result, training programs and discussions have been mostly catered to therapy providers.
With recent legal framework and regulatory developments in Australia, Alberta, Oregon and Colorado, psychedelic assisted therapy is slowly evolving and growing, and we see that it will take more than the sole efforts of a therapist to deliver psychedelic-assisted therapy, not just in a practical way, but also to meet regulatory requirements.
What’s YOUR role in the psychedelic landscape?
Join ATMA to discover the ways psychedelic assisted therapy is evolving into real life practice. to include the requirement of multiple different types of practitioners in different roles to conduct this therapy treatment.
Wherever you are a practicing therapist, nurse, interested physician, or just someone interested in this practice, if you are interested in psychedelic assisted therapy, you will benefit from this informative discussion with ATMA representatives.
What you’ll learn:
- Different engagement of Psilocybin and MDMA assisted therapy
- The roles of psychiatrists, physicians, therapists and facilitators in psychedelic assisted therapy in general
- Regulation of psychedelic therapy in Oregon, Colorado and their surrounding states
- The roles of those involved in psychedelic therapy in Alberta and the rest of Canada
- The roles of those involved in psychedelic therapy in Australia